№ files_lp_4_process_3_099047
File format: docx
Character count: 1244
File size: 84 KB
Announcement from a financial market source detailing the listing and terms of a newly issued credit-linked note on the JSE Interest Rate Market.
Date:
21 September 2021
Issuer:
FIRSTRAND BANK LIMITED
Instrument Type:
Credit-Linked Note
Bond Code:
FRC379
Nominal Issued:
R50,000,000.00
Issue Price:
100%
Coupon:
Floating (3 Month JIBAR + 340bps)
Trade Type:
Price
Final Maturity Date:
23 September 2023
Books Close Dates:
19 March, 19 June, 19 September, 19 December
Interest Payment Dates:
23 March, 23 June, 23 September, 23 December
Last Day to Register:
By 17:00 on 18 March, 18 June, 18 September, 18 December
Issue Date:
27 September 2021
Interest Commencement Date:
27 September 2021
First Interest Payment Date:
23 December 2021
ISIN:
ZAG000180142
Additional Information:
Senior Unsecured Unsubordinated
Settlement:
Dematerialised in Central Securities Depository (CSD) under JSE Rules
Contact:
Diboko Ledwaba, RMB, +27 11 685 5028; Corporate Action, JSE, +27 11 520 7000
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Date:
12 March 2021
Exchange:
JSE Limited
Market:
Interest Rate Market
Subject:
New Financial Instrument Listing
Issuer:
FIRSTRAND BANK LIMITED
Instrument Type:
Equity Structured Note
Bond Code:
FRS258
ISIN:
ZAG000174855
Nominal Issued:
R 260,392,055.00
Issue Price:
100%
Coupon:
Zero
Trade Type:
Price
Issue Date:
16 March 2021
Interest Commencement Date:
16 March 2021
First Interest Payment Date:
23 January 2024
Interest Payment Date(s):
23 January 2024
Books Close Date:
19 January 2024
Last Day to Register:
by 17:00 on 18 January 2024
Final Maturity Date:
23 January 2024
Security:
Unsecured
Settlement System:
Central Securities Depository (CSD) electronic settlement in terms of JSE Rules
Applicable Pricing Supplement:
https://clientportal.jse.co.za/Content/JSEPricingSupplementsItems/2021/FRS258%20PricingSupplement1603.pdf
Contact:
Corporate Actions, JSE, +27 11 5207000
Currency:
South African Rand (R)
Year:
2014
Region / City:
South Africa
Topic:
Financial Markets / Bonds
Document Type:
Market Notice
Institution:
JSE Limited
Issuer:
FirstRand Bank Limited
Programme Size:
R 50,000,000,000.00
Bond Codes:
FRJ17, FRJ18, FRJ19, FRJ20, FRX17, FRX18, FRX19, FRX23
Issue Dates:
10 February 2014
Contact Persons:
Simone Daws, Brendan Povey, Courtney Galloway, Diboko Ledwaba
Settlement Method:
Electronic via Central Depository (CSD)
Agency:
United States Securities and Exchange Commission
Form number:
Form 25
Document type:
Regulatory filing form
Jurisdiction:
United States
Legal basis:
Securities Exchange Act of 1934
Applicable rules:
Rule 12d2-2 (17 CFR 240.12d2-2); Rule 19d-1 (17 CFR 240.19d-1)
OMB control number:
3235-0080
OMB expiration date:
March 31, 2021
Filing system:
EDGAR
Effective delisting period:
10 days after filing
Effective withdrawal of registration period:
90 days after filing
Revision identifier:
SEC 1654 (03-06)
Year:
2025
Region / city:
Australia
Subject:
Oncology, Pharmaceutical Submission
Document Type:
Pharmaceutical Benefits Scheme (PBS) Submission
Organ / Institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
JANSSEN-CILAG PTY LTD
Target Audience:
Medical practitioners, healthcare professionals
Period of validity:
Ongoing
Approval Date:
Pending
Date of modifications:
N/A
Year:
2025
Region / City:
Uganda
Theme:
Procurement, Health Services, Public Contracts
Document Type:
Pre-Qualification Notice
Authority:
Mulago Specialised Women and Neonatal Hospital
Author:
Not specified
Target Audience:
Providers, Contractors, Suppliers
Period of Validity:
2025-2028
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2024
Region / Country:
Australia
Therapeutic Area:
Gastroenterology
Type of Document:
Regulatory submission / PBAC evaluation
Product:
Budesonide 4 mg suppository (Budenofalk®)
Comparator:
Budesonide 2 mg foam (Budenofalk®), prednisolone suppositories and enemas, hydrocortisone acetate enemas
Regulatory Authority:
TGA (Therapeutic Goods Administration)
Intended Use:
Short-term treatment of mild to moderate ulcerative colitis limited to the rectum
Prescriber Type:
Medical practitioners, Nurse practitioners
PBS Benefit Type:
Unrestricted
Maximum Quantity:
1 pack, 30 units
Treatment Duration:
up to 8 weeks per script
Clinical Evidence:
Phase 3, randomized, double-blind, double-dummy, non-inferiority trial (BUS-4/UCA)
Year:
2025
Region / City:
Windhoek
Subject:
Public Administration, Consultancy, Research
Document Type:
Official Announcement
Institution:
Namibia Institute of Public Administration and Management (NIPAM)
Author:
NIPAM
Target Audience:
Facilitators, Researchers, Consultants, Public Sector Experts
Period of Validity:
Until 10 February 2025
Approval Date:
Not specified
Date of Last Modification:
Not specified
Year:
2011
Regulation:
The Companies Regulations 2011, as amended
Region / Market:
Johannesburg Stock Exchange (JSE)
Document Type:
Regulatory guidance / compliance document
Scope:
Pre-Listing Statements (PLS), Revised Listing Particulars (RLP), Circulars
Language:
English
Applicable Parties:
Issuers and applicants seeking listing on JSE
Requirements:
Disclosure obligations, material contracts, corporate actions
Website Obligation:
Operational website for disclosure compliance
Audience:
Investors, shareholders
Year:
[Year]
Region / City:
Wellington
Topic:
Securities listing and quotation
Document Type:
Application
Organization:
NZ RegCo
Author:
[Issuer Name]
Target Audience:
NZX, securities issuers
Effective Period:
[Date]
Approval Date:
[Date]
Amendment Date:
[Date]
Year:
2023
Region / city:
Australia
Topic:
Oncology, Pharmaceuticals
Document Type:
Resubmission
Institution:
Australian Government, Pharmaceutical Benefits Advisory Committee
Author:
AstraZeneca Pty Ltd.
Target Audience:
Healthcare professionals, regulatory bodies
Effective Period:
Ongoing
Approval Date:
November 2021
Date of Changes:
November 2021
Note:
Year
Note:
Year
Year:
2021
Region / city:
United States
Subject:
COVID-19, Federal Audit Clearinghouse
Document Type:
Memo
Institution:
Department of Education
Author:
Phillip Juengst, Deputy Assistant Secretary
Target Audience:
Grant recipients of the Department of Education
Effective Date:
August 9, 2021
Date of Approval:
August 4, 2021
Questions:
[email protected]
Period of Applicability:
For single audit submissions on or after August 9, 2021
Document Description:
Guidance on how to report subprogram Assistance Listing Numbers (ALNs) with their alphas in the Federal Audit Clearinghouse single audit submission form for Department of Education programs.
Year:
2021
Region / city:
South Africa
Topic:
Financial Instruments, Exchange-Traded Notes
Document Type:
Listing Announcement
Organ / Institution:
FirstRand Bank Limited
Author:
FirstRand Bank Limited
Target Audience:
Investors, Financial Institutions
Period of Validity:
17 August 2021 – 17 August 2026
Approval Date:
17 August 2021
Amendment Date:
None
Year:
2018
Region / city:
Australia
Topic:
Immunisation, Hepatitis B
Document type:
Report
Agency / institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
Chief Medical Officer
Target audience:
Healthcare professionals, policymakers
Period of validity:
Until 31 December 2019
Date of approval:
June 2018
Date of amendments:
None
Year:
2021
Event:
Expert meeting
Location:
Online
Organization:
UNESCO
Topic:
Intangible cultural heritage, listing mechanisms
Type of document:
Report / Meeting overview
Author:
Rieks Smeets
Target audience:
UNESCO member states, cultural heritage experts
Dates of event:
26–27 May 2021
Time:
13:00–16:00 (Paris time / UTC+2)
Historical period covered:
1960s–2008
Year:
2021
Region / city:
Online
Subject:
Intangible Cultural Heritage
Document type:
Background Paper
Organization:
UNESCO
Author:
UNESCO Secretariat
Target audience:
Experts, States Parties, practitioners in the field of intangible cultural heritage
Duration:
May 2021 – ongoing
Approval date:
Not provided
Amendment date:
Not provided